CLINICAL_TRIALS
trial_result
· 2017-06-22
Clinical Trial Update: Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients [Phase 1]
Summary
A Phase 1 safety study of the Ventricular Partitioning Device Implant System for heart failure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CardioKinetix, Inc | Conditions: Heart Failure | Phase 1 | Status: COMPLETED